Emovi is accelerating its growth through a 15M$ Series C investment led by TVM Capital Life Science

Emovi is accelerating its growth through a 15M$ Series C investment led by TVM Capital Life Science

Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its global commercial activities. This 15M$ Series C investment is combined with other capital for a total of 20M$. Read more >>

Share this post